Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome

Breast Cancer Research and Treatment

Volumn 120, Issue 3, 2010, Pages 777-782

  Jensen, Uffe Birk ^a   Sunde, Lone ^a   Timshel, Susanne ^c   Halvarsson, Britta ^b   Nissen, Anja ^c   Bernstein, Inge ^c   Nilbert, Mef ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HELSINGBORG HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Hereditary cancer; HNPCC; MLH1; MMR; MSH2; MSH6

Indexed keywords

ONCOPROTEIN; PROTEIN MLH1; PROTEIN MLH2; PROTEIN MLH6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOSS; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MISMATCH REPAIR; PRIORITY JOURNAL; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DENMARK; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS, MULTIPLE PRIMARY; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PEDIGREE; URETHRAL NEOPLASMS;

EID: 77950861029     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0449-3     Document Type: Article

References (23)

1. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of canceranalyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78-85 (Pubitemid 30451850)
2. Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40(1): 17-22
3. Foulkes WD (2008) Inherited susceptibility to common cancers. N Engl J Med 359(20):2143-2153
4. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21(1):1-18 (Pubitemid 32619211)
5. Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG (2008) Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 74(3): 233-242
6. AarnioM,SankilaR,PukkalaE,SalovaaraR,AaltonenLA,delaChapelleA,PeltomakiP, MecklinJP,JarvinenHJ(1999)CancerriskinmutationcarriersofDNA-mismatch- repairgenes.IntJCancer81(2):21.4-218(Pubitemid29144749)
7. Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG (2009) Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 75(2): 141-149
8. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6): 1453-1456 (Pubitemid 29258894)
9. Watson P, Vasen HF, Mecklin JP, Bernstein I, Aarnio M, Jarvinen HJ, Myrhoj T, Sunde L, Wijnen JT, Lynch HT (2008) The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123(2):444-449 (Pubitemid 351842032)
10. Watson P, Lynch HT (1993) Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71(3):677-685 (Pubitemid 23051366)
11. Vasen HF, Morreau H, Nortier JW (2001) Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 68(6): 1533-1535
12. Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, du Sart D, Tucker K, Kirk J (2001) Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68(1):118-127
13. MullerA,EdmonstonTB,CoraoDA,RoseDG,PalazzoJP,BeckerH,FryRD,RueschoffJ, FishelR(2002) Exclusionofbreastcancerasanintegraltumorofhereditarynonpolyposiscolorectalca ncer.CancerRes62(4):1014-1019(Pubitemid34160280)
14. Itoh H, Houlston RS, Harocopos C, Slack J (1990) Risk of cancer death in first-degree relatives of patients with hereditary nonpolyposis cancer syndrome (Lynch type II): a study of 130 kindreds in the United Kingdom. Br J Surg 77(12):1367-1370
15. Westenend PJ, Schutte R, Hoogmans MM, Wagner A, Dinjens WN (2005) Breast cancer in an MSH2 gene mutation carrier. Hum Pathol 36(12): 1322-1326 (Pubitemid 41682289)
16. Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J (1996) Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 77(9):1836-1843 (Pubitemid 26125184)
17. Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH (1993) Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history, Genet Epidemiol 10(4):235-244
18. de Leeuw WJ, van Puijenbroek M, Tollenaar RA, Cornelisse CJ, Vasen HF, Morreau H (2003) Correspondence re: A. Muller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res, 62: 1014-1019, 2002.
19. Cancer Res 63(5): 1148-1149
20. Boyd J, Rhei E, Federici MG, Borgen PI, Watson P, Franklin B, Karr B, Lynch J, Lemon SJ, Lynch HT (1999) Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 53(1.):87-91 (Pubitemid 29123623)
21. Nilbert M, Kristoffersson U, Ericsson M, Johannsson O, Rambech E, Mangell P (2008) Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72. BMC Med Genet 9:101
22. Jass JR (2000) Pathology of hereditary nonpolyposis colorectal cancer. Ann N Y Acad Sci 910:62-73 discussion 73-164
23. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68(3):700-710 (Pubitemid 32203724)